Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2415106
Max Phase: Preclinical
Molecular Formula: C25H39NO
Molecular Weight: 369.59
Molecule Type: Small molecule
Associated Items:
ID: ALA2415106
Max Phase: Preclinical
Molecular Formula: C25H39NO
Molecular Weight: 369.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCc1ccccc1
Standard InChI: InChI=1S/C25H39NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(27)26-23-24-20-17-16-18-21-24/h6-7,9-10,16-18,20-21H,2-5,8,11-15,19,22-23H2,1H3,(H,26,27)/b7-6-,10-9-
Standard InChI Key: YJWLCIANOBCQGW-HZJYTTRNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 369.59 | Molecular Weight (Monoisotopic): 369.3032 | AlogP: 7.12 | #Rotatable Bonds: 16 |
Polar Surface Area: 29.10 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.56 | CX LogD: 7.56 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.24 | Np Likeness Score: 0.22 |
1. Wu H, Kelley CJ, Pino-Figueroa A, Vu HD, Maher TJ.. (2013) Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition., 21 (17): [PMID:23891163] [10.1016/j.bmc.2013.06.034] |
2. Hajdu Z, Nicolussi S, Rau M, Lorántfy L, Forgo P, Hohmann J, Csupor D, Gertsch J.. (2014) Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii., 77 (7): [PMID:24972328] [10.1021/np500292g] |
3. Cunningham CW.. (2019) Plant-Based Modulators of Endocannabinoid Signaling., 82 (3): [PMID:30816712] [10.1021/acs.jnatprod.8b00874] |
4. Singh N,Barnych B,Morisseau C,Wagner KM,Wan D,Takeshita A,Pham H,Xu T,Dandekar A,Liu JY,Hammock BD. (2020) N-Benzyl-linoleamide, a Constituent of Lepidium meyenii (Maca), Is an Orally Bioavailable Soluble Epoxide Hydrolase Inhibitor That Alleviates Inflammatory Pain., 83 (12): [PMID:33320645] [10.1021/acs.jnatprod.0c00938] |
5. Tena Perez, Victor, Apaza Ticona, Luis, Serban, Andreea Madalina, Acero Gomez, Javier, Rumbero SAnchez, Angel. (2020) Synthesis and biological screening of a library of macamides as TNF-alpha inhibitors, 11 (10): [PMID:33479624] [10.1039/d0md00208a] |
Source(1):